MoonLake Immunotherapeutics - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MLTX Nasdaq 2830 www.moonlaketx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) Rides HS Narrative Following Rebound As Undervalued View Holds - Oct 25th, 2026 4:15 am
MoonLake Immunotherapeutics (MLTX) Stock Trades Above Fair Value On Balance Sheet Questions - Oct 24th, 2026 8:07 pm
AbbVie Slips Behind Rivals as Lutikizumab Hits 31.4% Response in HS Trial - Oct 22nd, 2026 2:17 pm
MoonLake Soars 18% as Rival AbbVie’s Skin Disease Trial Data “Underwhelms” - Oct 22nd, 2026 11:17 am
MoonLake Immunotherapeutics Makes Case for Sonelokimab Approval, RBC Says - Oct 16th, 2026 9:35 am
MoonLake Immunotherapeutics Could Win FDA Approval for Sonelokimab by Year-End 2027, Wedbush Says - Oct 5th, 2026 9:26 am
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight - Sep 21st, 2026 11:00 am
MLTX Stock On Track For Worst Week Since Last Fall As FDA Filing Date For Skin Disease Drug Draws Near - Sep 11th, 2026 11:48 am
MoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - Aug 10th, 2026 7:24 am
MLTX Stock Under Pressure As Investors Await Psoriatic Arthritis Trial Data - Aug 3rd, 2026 11:30 am
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High? - Jul 31st, 2026 7:55 am
SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears - Jul 12th, 2026 8:48 pm
MoonLake Immunotherapeutics' CFO Sells 39K Shares - Jul 3rd, 2026 8:34 am
MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa - Jun 30th, 2026 7:22 am
How Investors May Respond To MoonLake Immunotherapeutics (MLTX) VELA Data And Upsized Follow-On Offering - Jun 25th, 2026 6:07 am
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday - Jun 24th, 2026 6:09 pm
MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development - Jun 24th, 2026 5:48 am